Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2025-07-02 (olympia.gr)
EURACTIV: The Brussels top prosecutor reveals the scandals that tried to bury - OPECEPE, contract 717, Novartis
Rizili without borders ... This is the harsh reality for Greece, which is at the heart of international reports every now and then
Read more
2025-02-18 (ieidiseis.gr)
Nikos Androulakis: Justice
Kyriakos Mitsotakis and Port, despite being placed Nikos Androulakis in a very large list of those who question justice. Summary unaccounted for ...
Read more
2025-01-21 (documentonews.gr)
Novartis scandal: Criminal prosecution for misdemeanors against the two protected witnesses -
Criminal prosecution for the offenses of perjury and perjury was brought against the two protected witnesses of the Novartis scandal, as a result of
Read more
2025-01-21 (documentonews.gr)
Novartis scandal: Criminal prosecution for misdemeanors against the two protected witnesses -
Criminal prosecution for the offenses of perjury and perjury was brought against the two protected witnesses of the Novartis scandal, as a result of
Read more
2025-01-21 (thepressproject.gr)
Novartis scandal: Former protected witnesses face criminal prosecution - The Press Project - News, Analysis, Radio, TV
Criminal charges have been filed against two former protected witnesses, known under the pseudonyms "Aikaterini Kelesi" and "Maximos Sarafis", in the Novartis bribery case, just two months after their protection…
Read more
2025-01-21 (thepressproject.gr)
Novartis scandal: Former protected witnesses face criminal prosecution - The Press Project - News, Analysis, Radio, TV
Criminal charges have been filed against two former protected witnesses, known under the pseudonyms "Aikaterini Kelesi" and "Maximos Sarafis", in the Novartis bribery case, just two months after their protection…
Read more
2025-01-19 (tvxs.gr)
Yannis Mylopoulos / President of the (New) Republic -
The Greece of 2025 is a country in which the rule of law recedes and democracy suffers, from an authoritarian government and oligarchs
Read more
2025-01-09 (beckersasc.com)
Anti-Kickback Statute grows in scope: 5 things to know
"Learn about the recent whistleblower lawsuit against Novartis and the new development in enforcing the Anti-Kickback Statute. Find out the five key takeaways a
Read more
2025-01-09 (beckersasc.com)
Anti-Kickback Statute grows in scope: 5 things to know
"Learn about the recent whistleblower lawsuit against Novartis and the new development in enforcing the Anti-Kickback Statute. Find out the five key takeaways a
Read more
2024-12-30 (finanzen.ch)
Novartis shares hardly changed: Novartis has to face allegations of bribery again - positive study results on gene therapy | 12/30/24 |
The pharmaceutical company Novartis will probably have to face bribery allegations again in court in the USA from a whistleblower for the distribution of the MS drug Gilenya.
Read more
2024-12-28 (isvicreninsesi.ch)
NOVARTIS WILL BE TRIED AGAIN IN THE USA ON ALLEGATIONS OF BRIBING DOCTORS - Voice of Switzerland - Online Newspaper
Swiss pharmaceutical giant Novartis is facing a dubious lawsuit again in the United States. The company will be prosecuted for bribing doctors to promote the multiple sclerosis (MS) drug Gilenya. This case was revived after a whistleblower lawsuit was filed by a former employee. Details of the CaseThe US Manhattan 2nd Circuit Court of Appeals annulled the decision of a district court in New York to reject the case in 2022. Swiss pharmaceutical giant Novartis is facing a suspicious case again in the USA. The company will be prosecuted for bribing doctors to promote the multiple sclerosis (MS) drug Gilenya. This case was revived after a whistleblower lawsuit was filed by a former employee.
Read more
2024-12-28 (watson.ch)
Novartis has to face bribery allegations again in the USA
The pharmaceutical company Novartis will probably have to face again in court in the USA the allegations of bribery by a whistleblower for the distribution of the MS drug...
Read more